BROOKE HOUSHIAR: Open Payments
NPI 1295469765 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$223 in 10 payments from 6 companies in 2025. Trend: 2023 $213 · 2024 $42 · 2025 $223
Food & beverage: $223
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $85 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $33 |
| Novo Nordisk Inc | 1 | $27 |
| Medtronic, Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: CAPLYTA, AUSTEDO XR, Wegovy, INTELLIS ADAPTIVESTIM, MOUNJARO, KISUNLA, GARDASIL 9.
Industry payments across SC — which companies pay providers there.
